摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3S,5S,6S,7R,8S,9R,12R,13R,14S,15R)-6-[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-8-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-1,11-dioxaspiro[2.13]hexadecane-10,16-dione;phosphoric acid | 7060-74-4

中文名称
——
中文别名
——
英文名称
(3S,5S,6S,7R,8S,9R,12R,13R,14S,15R)-6-[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-8-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-1,11-dioxaspiro[2.13]hexadecane-10,16-dione;phosphoric acid
英文别名
——
(3S,5S,6S,7R,8S,9R,12R,13R,14S,15R)-6-[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-8-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-1,11-dioxaspiro[2.13]hexadecane-10,16-dione;phosphoric acid化学式
CAS
7060-74-4
化学式
C35H64NO16P
mdl
——
分子量
785.9
InChiKey
RLPCJGKQKFMBEI-JWNQHVKNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    145-147℃
  • 溶解度:
    可溶于DMSO(少许)、甲醇(少许)

计算性质

  • 辛醇/水分配系数(LogP):
    0.98
  • 重原子数:
    53
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.94
  • 拓扑面积:
    244
  • 氢给体数:
    6
  • 氢受体数:
    17

安全信息

  • 危险品标志:
    T+
  • 安全说明:
    S22,S24/25,S28,S36/37,S45
  • 危险类别码:
    R28
  • 危险品运输编号:
    UN2811 6.1/PG 2

SDS

SDS:3ecaa4019f145114e23ca7b2ef48a81a
查看

制备方法与用途

磷酸竹桃霉素是一种大环内酯性抗菌素,分子式为C35H61NO12·H3PO4,是由抗菌素链霉菌生长时产生的。它在化学结构、作用和用法上与红霉素相似,但抗菌作用较弱。主要用于治疗对其他全身性抗菌素具有耐药性的链球菌和其他革兰氏阳性菌引起的感染。通常通过胃肠外给药。本信息由Chemicalbook晓楠编辑于2015-09-08。

文献信息

  • [EN] ANTIBACTERIAL QUINOLINE DERIVATIVES<br/>[FR] DÉRIVÉS DE QUINOLÉINE ANTIBACTÉRIENS
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2013160435A1
    公开(公告)日:2013-10-31
    The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or Formula (Ib): including any stereochemically isomeric form thereof, a pharmaceutically acceptable salt thereof, a N-oxide form thereof or a solvate thereof. The claimed compounds are useful for the treatment of a bacterial infection. Also 1 claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of a bacterial infection and a process for preparing the claimed compounds.
    本发明涉及根据一般式(Ia)或式(Ib)的新型取代喹啉衍生物:包括其任何立体化异构体、药学上可接受的盐、N-氧化物形式或溶剂化合物。所述化合物适用于治疗细菌感染。此外,还声明了包含药学上可接受的载体和所述化合物的治疗有效量作为活性成分的组合物,所述化合物或组合物用于制造治疗细菌感染药物的用途以及制备所述化合物的方法。
  • ANTIBACTERIAL QUINOLINE DERIVATIVES
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:US20150065502A1
    公开(公告)日:2015-03-05
    The present invention relates to novel substituted quinoline derivatives according to the general Formula (Ia) or Formula (Ib): including any stereochemically isomeric form thereof, a pharmaceutically acceptable salt thereof, a N-oxide form thereof or a solvate thereof. The claimed compounds are useful for the treatment of a bacterial infection. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of a bacterial infection and a process for preparing the claimed compounds.
    本发明涉及根据一般式(Ia)或式(Ib)的新型取代喹啉衍生物:包括其任何立体化异构体,其药学上可接受的盐,其N-氧化物形式或其溶剂合物。所述化合物适用于治疗细菌感染。还声明了一种包含药学上可接受的载体和所述化合物的治疗有效量作为活性成分的组合物,所述化合物或组合物用于制造治疗细菌感染的药物以及制备所述化合物的方法。
  • [EN] 2-METHYLTHIOPYRROLIDINES AND THEIR USE FOR MODULATING BACTERIAL QUORUM SENSING<br/>[FR] 2-MÉTHYLTHIOPYRROLIDINES ET LEUR UTILISATION POUR MODULER LA DÉTECTION DU QUORUM BACTÉRIEN
    申请人:FLORIDA INT UNIV BOARD TRUSTEES
    公开号:WO2012174511A1
    公开(公告)日:2012-12-20
    Compounds of Formula (I) are disclosed herein and their use in inhibiting quorum sensing in bacteria.
    本文披露了化学式(I)的化合物及其在抑制细菌中的群体感应中的应用。
  • Deubiquitinase Inhibitors and Methods for Use of the Same
    申请人:Donato Nicholas J.
    公开号:US20120077806A1
    公开(公告)日:2012-03-29
    Disclosed herein are methods of inhibiting a deubiquitinase (DUB), methods of treating pathogenic infections (e.g., viral, bacterial, and/or parasitic), methods of inhibiting cell proliferation, methods of treating a neurodegenerative disease, methods of treating one or more symptoms of a neurodegenerative disease or a genetic disorder, and compounds.
    本文揭示了抑制去泛素化酶(DUB)的方法,治疗病原体感染(例如病毒、细菌和/或寄生虫)的方法,抑制细胞增殖的方法,治疗神经退行性疾病的方法,治疗神经退行性疾病或遗传疾病症状的方法,以及化合物。
  • METHODS AND COMPOSITIONS FOR TREATING INFECTION
    申请人:UNIVERSITY OF ROCHESTER
    公开号:US20150238473A1
    公开(公告)日:2015-08-27
    Provided herein are compositions and methods for treating or preventing infection.
    本文提供了用于治疗或预防感染的组合物和方法。
查看更多